- Report
- August 2022
- 125 Pages
Global
From €4541EUR$4,750USD£3,902GBP
- Report
- August 2022
- 120 Pages
Global
From €4541EUR$4,750USD£3,902GBP
- Report
- January 2022
- 120 Pages
Global
From €4541EUR$4,750USD£3,902GBP
- Report
- May 2023
- 450 Pages
Global
From €4780EUR$5,000USD£4,108GBP
- Drug Pipelines
- January 2023
- 30 Pages
Global
From €2629EUR$2,750USD£2,259GBP
- Drug Pipelines
- January 2023
- 30 Pages
Global
From €2629EUR$2,750USD£2,259GBP
- Drug Pipelines
- January 2023
- 30 Pages
Global
From €2629EUR$2,750USD£2,259GBP
- Report
- September 2022
- 141 Pages
Global
From €3776EUR$3,950USD£3,245GBP
- Report
- August 2022
- 30 Pages
Global
From €2629EUR$2,750USD£2,259GBP
- Report
- January 2022
- 200 Pages
Global
From €7170EUR$7,500USD£6,162GBP
- Report
- January 2022
- 60 Pages
Global
From €3776EUR$3,950USD£3,245GBP
- Report
- January 2022
- 60 Pages
Global
From €3776EUR$3,950USD£3,245GBP
- Report
- February 2021
- 30 Pages
Global
From €3107EUR$3,250USD£2,670GBP
- Report
- September 2022
- 283 Pages
Global
From €7170EUR$7,500USD£6,162GBP
- Report
- January 2023
- 119 Pages
Global
From €4302EUR$4,500USD£3,697GBP
- Report
- August 2022
- 119 Pages
Global
From €4302EUR$4,500USD£3,697GBP
- Report
- December 2021
- 99 Pages
Global
From €4302EUR$4,500USD£3,697GBP
- Report
- October 2021
- 202 Pages
Global
From €3045EUR$3,185USD£2,617GBP
€4350EUR$4,550USD£3,738GBP
- Report
- April 2023
- 115 Pages
Global
From €4541EUR$4,750USD£3,902GBP
- Report
- March 2021
Global
From €3824EUR$4,000USD£3,286GBP
The Immunoglobulin market is a segment of the Immune Disorders Drugs market, which focuses on treatments for conditions related to the immune system. Immunoglobulin (Ig) is a type of protein found in the blood that helps fight infection and disease. It is used to treat a variety of immune-related conditions, including autoimmune diseases, allergies, and infections. Immunoglobulin therapies are typically administered intravenously or subcutaneously, and can be used to replace or supplement the body's natural Ig production.
The Immunoglobulin market is highly competitive, with a number of companies offering a range of products. These products vary in terms of dosage, delivery method, and cost. Companies in the market are focused on developing new therapies and improving existing ones, as well as expanding their product portfolios.
Some of the major companies in the Immunoglobulin market include CSL Behring, Grifols, Kedrion, Octapharma, and Shire. Show Less Read more